You are here

Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

PCSK9 drugmakers go Big Data to ID more eligible patients

Fierce Pharma Marketing

Wed, 10/21/15 - 11:34 am

Tags:

PCSK9 inhibitors, patients, Big Data, Amgen, Sanofi, Regeneron, Repatha, Praluent

3 Biotechs Growing Faster Than Apple

Motley Fool

Mon, 10/19/15 - 09:41 am

Tags:

biotech, Alexion, Celgene, Regeneron

Lilly Loses Its Bloom; Amgen, Regeneron Blossom

Barron's

Mon, 10/12/15 - 11:51 am

Tags:

Eli Lilly, Amgen, Regeneron, evacetrapib, Repatha

Express Scripts to Cover Both New Cholesterol Drugs

NASDAQ.com

Tue, 10/6/15 - 07:00 pm

Tags:

Express Scripts, Praluent, Repatha, PCSK9 inhibitors, Sanofi, Amgen, Regeneron

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Motley Fool

Tue, 10/6/15 - 06:57 pm

Tags:

Regeneron, vaccines, ebola virus, BARDA

Regeneron inks a $325M deal, selling Asian rights to a pain treatment

Fierce Biotech

Fri, 10/2/15 - 04:56 pm

Tags:

Regeneron, Mitsubishi Tanabe Pharma, musculoskeletal pain, fasinumab

New cholesterol drugs won't be budget busters -Express Scripts

Yahoo/Reuters

Thu, 10/1/15 - 09:10 am

Tags:

Express Scripts, drug pricing, PCSK9 inhibitors, Repatha, Praluent, Amgen, Regeneron, Sanofi

Regeneron Pharmaceuticals and Sanofi Grab Another Important Win

Motley Fool

Wed, 09/30/15 - 09:32 am

Tags:

Regeneron, Sanofi, Europe, Praluent, PCSK9 inhibitors

Three Pharmas Highlight Contrasting Approaches To Product Innovation

Forbes

Tue, 09/29/15 - 10:12 pm

Tags:

innovation, Regeneron, Allergan, Teva Pharmaceutical

The Price War for New Cholesterol Drugs Is Heating Up

Motley Fool

Fri, 09/25/15 - 08:48 pm

Tags:

PCSK9 inhibitors, drug pricing, Regeneron, Sanofi, Amgen, Praluent, Repatha

Regeneron Pharmaceuticals Inc (REGN) Stock Update: Praluent And Eylea Drive Future Growth

Bidness, ETC

Wed, 09/23/15 - 09:49 am

Tags:

Regeneron, Praluent, Eylea

Amgen & Regeneron: No, Clinton Tweet Won’t Kill Anti-Cholesterol Drugs

Barron's

Tue, 09/22/15 - 11:41 am

Tags:

Amgen, Regeneron, Hillary Clinton

Regeneron Announces Agreement with BARDA for the Development of New Antibody Treatment for Ebola

Yahoo

Tue, 09/22/15 - 09:33 am

Tags:

Regeneron, BARDA, ebola virus, monoclonal antibodies

AZ's high-powered Crestor could gain from payer limits on PCSK9 meds

Fierce Pharma Marketing

Fri, 09/11/15 - 09:55 am

Tags:

AstraZeneca, Crestor, PCSK9 inhibitors, drug pricing, Repatha, Praluent, Amgen, Regeneron, Sanofi

Independent group finds new cholesterol drugs far too costly

Yahoo/Reuters

Wed, 09/9/15 - 10:12 pm

Tags:

drug pricing, PCSK9 inhibitors, Praluent, Repatha, Amgen, Sanofi, Regeneron

PCSK9 Inhibitor Therapies Face Pricing Pressures

Yahoo/Market Realist

Mon, 09/7/15 - 11:45 am

Tags:

PCSK9 inhibitors, drug pricing, Praluent, Repatha, Amgen, Regeneron, Sanofi

The Next Blockbusters Could Be Balms For Aging Eyes

Investors.com

Thu, 09/3/15 - 09:10 am

Tags:

age-related macular degeneration, Bayer, Regeneron, Ophthotech, Allergan, Novartis, Applied Genetic Technologies, Avalanche Biotechnologies, Roche, Lucentis, Eylea

2 major insurers draw lines in the sand for pricey PCSK9 coverage

BioPharma Dive

Wed, 09/2/15 - 12:34 pm

Tags:

PCSK9 inhibitors, insurers, Regeneron, Sanofi, Amgen, Praluent, Repatha

Approval Of Repatha May Give Amgen A $5B Boost

Seeking Alpha

Mon, 08/31/15 - 05:28 pm

Tags:

Repatha, Amgen, PCSK9 inhibitors, Praluent, Sanofi, Regeneron

Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?

Bidness, ETC

Mon, 08/31/15 - 09:06 am

Tags:

PCSK9 inhibitors, Amgen, Regeneron, Repatha, Praluent

Pages

last 30 twitter posts